Back
31
Day Range
$183.95
$191.50
52-Week Range
$148.33
$228.92
Volume
578,018
50D / 200D Avg
$202.59
/
$206.30
Prev Close
$181.46
Price History
Financial Trends
Peer Comparison
vs Consumer Cyclical sector median (609 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 10.1 | 11.2 |
| P/B | 2.8 | 1.4 |
| ROE % | 27.1 | 10.7 |
| Net Margin % | 2.4 | 5.1 |
| Rev Growth 5Y % | 1.7 | 8.3 |
| D/E | 4.4 | 0.8 |
Key Takeaways
Revenue grew 1.69% annually over 5 years — modest growth
ROE of 27.05% indicates high profitability
Debt/Equity of 4.35 — high leverage
Negative free cash flow of -197.50M
P/E of 10.13 — trading at a low valuation
Capital efficient — spends only 1.12% of revenue on capex
Growth
Revenue Growth (5Y)
1.69%
Revenue (1Y)3.24%
Earnings (1Y)-6.23%
FCF Growth (3Y)N/A
Quality
Return on Equity
27.05%
ROIC7.99%
Net Margin2.35%
Op. Margin4.83%
Safety
Debt / Equity
4.35
Current Ratio0.84
Interest Coverage3.62
Valuation
P/E Ratio
10.13
P/B Ratio2.81
EV/EBITDA12.51
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.24% | Revenue Growth (3Y) | 1.26% |
| Earnings Growth (1Y) | -6.23% | Earnings Growth (3Y) | -20.27% |
| Revenue Growth (5Y) | 1.69% | Earnings Growth (5Y) | -17.08% |
| Profitability | |||
| Revenue (TTM) | 27.63B | Net Income (TTM) | 649.10M |
| ROE | 27.05% | ROA | 4.51% |
| Gross Margin | 17.00% | Operating Margin | 4.83% |
| Net Margin | 2.35% | Free Cash Flow (TTM) | -197.50M |
| ROIC | 7.99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4.35 | Current Ratio | 0.84 |
| Interest Coverage | 3.62 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 10.13 | P/B Ratio | 2.81 |
| P/S Ratio | 0.24 | PEG Ratio | 12.18 |
| EV/EBITDA | 12.51 | Dividend Yield | 0.00% |
| Market Cap | 6.57B | Enterprise Value | 16.70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 27.63B | 26.77B | 26.95B | 26.99B | 25.84B |
| Net Income | 649.10M | 692.20M | 1.02B | 1.38B | 1.37B |
| EPS (Diluted) | 17.04 | 16.92 | 22.74 | 24.29 | 18.31 |
| Gross Profit | 4.70B | 4.79B | 5.13B | 5.27B | 4.95B |
| Operating Income | 1.33B | 1.31B | 1.65B | 2.02B | 1.90B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 14.39B | 13.00B | 11.98B | 10.06B | 8.94B |
| Total Liabilities | 12.05B | 10.54B | 9.77B | 8.01B | 6.57B |
| Shareholders' Equity | 2.34B | 2.46B | 2.21B | 2.05B | 2.38B |
| Total Debt | 10.18B | 8.65B | 8.12B | 6.42B | 4.95B |
| Cash & Equivalents | 58.60M | 101.50M | 60.80M | 72.60M | 60.40M |
| Current Assets | 4.65B | 4.70B | 4.31B | 3.14B | 2.81B |
| Current Liabilities | 5.54B | 6.31B | 5.58B | 3.41B | 3.06B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#315 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026